Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous skeletal myoblast cell sheet transplantation for dilated cardiomyopathy
jRCTb050200131Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jan 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in dilated cardiomyopathy (DCM), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Improvement of left ventricular ejection fraction. Started Jan 2023; status: completed.
02
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on jRCTb050200131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTb050200131.